Price Regulation's The Game Theory Perspective on the Equilibrium between Regulated Price and R & D Investment

Jiantao Cao,Jin Ma
DOI: https://doi.org/10.3969/j.issn.1005-9679.2015.01.007
2015-01-01
Abstract:As to the current dilema of new drugs' higher prices and pharmaceutical manufacturers' lower expenditures in R&D, we attempt to solve it from the game theory perspective and price regulation. We build 2-stage game models with the government as a leader and a pharmaceutical manufacturer as a follower, discuss the situation of which the government considers patients utility alone, and prove Nash equilibriums existing. The theoretical analysis shows that the government 's pricing strategies are scientific and efficient for guaranteeing patients utility optimally and promoting R&D investment level feasiblely. Furthermore, it is more of positive signiifcance that the increase of R&D expenditures results from whether higher price is determined on new drugs with lower price elasticity or lower price determined on the ones with extremely higher elasticity.
What problem does this paper attempt to address?